During the past decade, Medical Oncology Associates of Augusta conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 25 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Oncology Associates of Augusta" #1 sponsor was "SCRI Development Innovations, LLC" with 12 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored, "Accelerated Community Oncology Research Network" with 6 trials sponsored and "SWOG Cancer Research Network" with 6 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology Associates of Augusta" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Genentech, Inc." with 6 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Amgen" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology Associates of Augusta" are "Breast Cancer" (12 trials), "Lung Cancer" (4 trials), "Invasive Breast Carcinoma" (3 trials), "Multiple Myeloma" (3 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Medical Oncology Associates of Augusta" in a lesser frequency.

Most popular intervention types in "Medical Oncology Associates of Augusta" are "Drug" (56 trials), "Other" (15 trials), "Biological" (14 trials), "Procedure" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Quality-of-Life Assessment" (8 trials), "Carboplatin" (7 trials), "Questionnaire Administration" (6 trials) and "Bevacizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology Associates of Augusta" are 49 trials for "All" genders, 17 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Oncology Associates of Augusta". undefined are not yet recruiting, 6 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Medical Oncology Associates of Augusta, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology Associates of Augusta, 2 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".